<p>药明康德 (OTCMKTS:DUFRY - 获取免费报告) 在十月份的空头头寸显著增加。截至 10 月 31 日，空头头寸总计 39,400 股，比 10 月 15 日的 28,000 股增加了 40.7%。根据 121,100 股的平均交易量，目前的空头头寸比率为 0.3 天。</p>
<h2>药明康德价格表现</h2>
<ul>
<li>Dufry AG 股票是旅游复苏的投资机会</li>
</ul>
<p>药明康德的股票在周五的交易时段上涨了 0.05 美元，达到 3.67 美元。该公司交易了 116,749 股，较其平均交易量 79,617 股有所增加。该公司的 50 日移动平均为 3.91 美元，200 日移动平均为 3.90 美元。药明康德的 1 年最低价为 3.38 美元，1 年最高价为 4.25 美元。</p>
<h2>药明康德公司简介</h2>
<p>(获取免费报告)</p>
<p>药明康德作为一家旅游零售商运营。公司的零售品牌包括 Dufry、World Duty Free、Nuance、Hellenic Duty Free、Zurich Duty-Free 或 Stockholm Duty-Free、Autogrill 和 HMSHost 品牌下的一般旅游零售商店；Dufry 购物商店；品牌专卖店；主要以 Hudson 品牌为主的便利店；以及专业商店和主题商店。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过药明康德</li>
<li>宝洁 NYSE: PG 在不稳定的指引后回落</li>
<li>ORIC: 与两家制药巨头合作，分析师预计上涨超过 100%</li>
<li>投资建筑类股票</li>
<li>Freeport-McMoRan，铜需求短期痛苦，长期收益</li>
<li>市值计算器：如何计算市值</li>
<li>现在是增持房屋建筑商的时候吗？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<p>→ 有一家鲜为人知的公司正在改变战争（来自 Reticulate）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDUzMg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDUzMg"/></p>
<h2>你现在应该投资 1,000 美元在药明康德吗？</h2>
<p>在你考虑药明康德之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而药明康德并不在名单上。</p>
<p>虽然药明康德目前在分析师中被评为 “持有”，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

杜福瑞(ADR)

<p>Avolta AG (OTCMKTS:DUFRY) 在十月份的空头头寸显著增加了 40.7%，从 28,000 股上升至 39,400 股，截止到 10 月 31 日。根据平均交易量 121,100 股，目前的空头头寸比率为 0.3 天。Avolta 的股价波动，最近的交易价格为 0.67。该公司作为一家旅行零售商，旗下拥有多个品牌</p>

<p>Avolta AG (OTCMKTS:DUFRY - Get Free Report) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 39,400 shares, an increase of 40.7% from the October 15th total of 28,000 shares. Based on an average trading volume of 121,100 shares, the short-interest ratio is presently 0.3 days.</p>
<div class="lb-trans"><p>药明康德 (OTCMKTS:DUFRY - 获取免费报告) 在十月份的空头头寸显著增加。截至 10 月 31 日，空头头寸总计 39,400 股，比 10 月 15 日的 28,000 股增加了 40.7%。根据 121,100 股的平均交易量，目前的空头头寸比率为 0.3 天。</p>
</div><h2>Avolta Price Performance</h2>
<div class="lb-trans"><h2>药明康德价格表现</h2>
</div><ul>
<li>Dufry AG Stock is a Travel Recovery Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Dufry AG 股票是旅游复苏的投资机会</li>
</ul>
</div><p>Shares of Avolta stock traded up $0.05 during trading hours on Friday, hitting $3.67. 116,749 shares of the company were exchanged, compared to its average volume of 79,617. The business has a 50-day moving average of $3.91 and a 200-day moving average of $3.90. Avolta has a 1 year low of $3.38 and a 1 year high of $4.25.</p>
<div class="lb-trans"><p>药明康德的股票在周五的交易时段上涨了 0.05 美元，达到 3.67 美元。该公司交易了 116,749 股，较其平均交易量 79,617 股有所增加。该公司的 50 日移动平均为 3.91 美元，200 日移动平均为 3.90 美元。药明康德的 1 年最低价为 3.38 美元，1 年最高价为 4.25 美元。</p>
</div><h2>Avolta Company Profile</h2>
<div class="lb-trans"><h2>药明康德公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Avolta AG operates as a travel retailer. The company's retail brands include general travel retail shops under the Dufry, World Duty Free, Nuance, Hellenic Duty Free, Zurich Duty-Free or Stockholm Duty-Free, Autogrill, and HMSHost brands; Dufry shopping stores; brand boutiques; convenience stores primarily under the Hudson brand; and specialized shops and theme stores.</p>
<div class="lb-trans"><p>药明康德作为一家旅游零售商运营。公司的零售品牌包括 Dufry、World Duty Free、Nuance、Hellenic Duty Free、Zurich Duty-Free 或 Stockholm Duty-Free、Autogrill 和 HMSHost 品牌下的一般旅游零售商店；Dufry 购物商店；品牌专卖店；主要以 Hudson 品牌为主的便利店；以及专业商店和主题商店。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Avolta</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>ORIC: Working with Two Pharma Giants, Analysts See +100% Upside</li>
<li>Investing in Construction Stocks</li>
<li>Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain</li>
<li>Market Cap Calculator: How to Calculate Market Cap</li>
<li>Time to Load Up on Home Builders?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过药明康德</li>
<li>宝洁 NYSE: PG 在不稳定的指引后回落</li>
<li>ORIC: 与两家制药巨头合作，分析师预计上涨超过 100%</li>
<li>投资建筑类股票</li>
<li>Freeport-McMoRan，铜需求短期痛苦，长期收益</li>
<li>市值计算器：如何计算市值</li>
<li>现在是增持房屋建筑商的时候吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><p>→ There is a little known company that is changing warfare (From Reticulate)(Ad)</p>
<div class="lb-trans"><p>→ 有一家鲜为人知的公司正在改变战争（来自 Reticulate）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDUzMg" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10532&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Avolta right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在药明康德吗？</h2>
</div><p>Before you consider Avolta, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑药明康德之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avolta wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而药明康德并不在名单上。</p>
</div><p>While Avolta currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然药明康德目前在分析师中被评为 “持有”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

杜福瑞 (ADR)（OTCMKTS:DUFRY）的空头头寸增加了 40.7%